Financial Statements
The above statement should be read in conjunction with the accompanying Notes
The above statement should be read in conjunction with the accompanying Notes
The above statement should be read in conjunction with the accompanying Notes
The above statement should be read in conjunction with the accompanying Notes
The above statement should be read in conjunction with the accompanying Notes
The above statement should be read in conjunction with the accompanying Notes
The above statement should be read in conjunction with the accompanying Notes
The above statement should be read in conjunction with the accompanying Notes
The above statement should be read in conjunction with the accompanying Notes
The above statement should be read in conjunction with the accompanying Notes
The above statement should be read in conjunction with the accompanying Notes
TABLE OF CONTENTS - Notes
Note: 1: Summary of Significant Accounting Policies
Note: 2: Events After the Reporting Period
Note: 3: Expenses
Note: 4: Income
Note: 5: Fair Value Measurements
Note: 6: Financial Assets
Note: 7: Non-Financial Assets
Note: 8: Payables
Note: 9: Provisions
Note: 10: Cash Flow Reconciliation
Note: 11: Contingent Assets and Liabilities
Note: 12: Senior Executive Remuneration
Note: 13: Remuneration of Auditors
Note: 14: Financial Instruments
Note: 15: Financial Assets Reconciliation
Note: 16: Administered - Expenses
Note: 17: Administered - Income
Note: 18: Administered - Fair Value Measurements
Note: 19: Administered - Financial Assets
Note: 20: Administered - Non-Financial Assets
Note: 21: Administered - Payables
Note: 22: Administered - Cash Flow Reconciliation
Note: 23: Administered - Contingent Assets and Liabilities
Note: 24: Administered - Investments
Note: 25: Administered - Financial Instruments
Note: 26: Administered Financial Assets Reconciliation
Note: 27: Appropriations
Note: 28: Special Accounts and FMA Act Section 39 Investments
Note: 29: Compensation and Debt Relief
Note: 30: Compliance with Statutory Conditions for Payments from the Consolidated Revenue Fund
Note: 31: Reporting of Outcomes
Note: 32: Net Cash Appropriation Arrangements
NATIONAL BLOOD AUTHORITY
NOTES TO AND FORMING PART OF THE FINANCIAL STATEMENTS
for the year ended 30 June 2014
Note: 1: Summary of Significant Accounting Policies
Download NBA accessible pdf